Global Recombinant DNA Technology Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Recombinant DNA Technology Market Size was estimated at USD 3291.61 million in 2023 and is projected to reach USD 5399.92 million by 2029, exhibiting a CAGR of 8.60% during the forecast period.
This report provides a deep insight into the global Recombinant DNA Technology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Recombinant DNA Technology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Recombinant DNA Technology market in any manner.
Global Recombinant DNA Technology Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Sanofi
Merck KGaA
Profacgen
Biocon
GlaxoSmithKline
Cibus
Horizon Discovery Group
New England Biolabs
Market Segmentation (by Type)
Therapeutic Agent
Vaccine
Biotech Crops
Specialty Chemicals
Market Segmentation (by Application)
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Recombinant DNA Technology Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Recombinant DNA Technology Market Size was estimated at USD 3291.61 million in 2023 and is projected to reach USD 5399.92 million by 2029, exhibiting a CAGR of 8.60% during the forecast period.
This report provides a deep insight into the global Recombinant DNA Technology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Recombinant DNA Technology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Recombinant DNA Technology market in any manner.
Global Recombinant DNA Technology Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Sanofi
Merck KGaA
Profacgen
Biocon
GlaxoSmithKline
Cibus
Horizon Discovery Group
New England Biolabs
Market Segmentation (by Type)
Therapeutic Agent
Vaccine
Biotech Crops
Specialty Chemicals
Market Segmentation (by Application)
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Recombinant DNA Technology Market
- Overview of the regional outlook of the Recombinant DNA Technology Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Recombinant DNA Technology Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Recombinant DNA Technology
1.2 Key Market Segments
1.2.1 Recombinant DNA Technology Segment by Type
1.2.2 Recombinant DNA Technology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RECOMBINANT DNA TECHNOLOGY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Recombinant DNA Technology Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Recombinant DNA Technology Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RECOMBINANT DNA TECHNOLOGY MARKET COMPETITIVE LANDSCAPE
3.1 Global Recombinant DNA Technology Sales by Manufacturers (2019-2024)
3.2 Global Recombinant DNA Technology Revenue Market Share by Manufacturers (2019-2024)
3.3 Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Recombinant DNA Technology Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Recombinant DNA Technology Sales Sites, Area Served, Product Type
3.6 Recombinant DNA Technology Market Competitive Situation and Trends
3.6.1 Recombinant DNA Technology Market Concentration Rate
3.6.2 Global 5 and 10 Largest Recombinant DNA Technology Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RECOMBINANT DNA TECHNOLOGY INDUSTRY CHAIN ANALYSIS
4.1 Recombinant DNA Technology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RECOMBINANT DNA TECHNOLOGY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RECOMBINANT DNA TECHNOLOGY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant DNA Technology Sales Market Share by Type (2019-2024)
6.3 Global Recombinant DNA Technology Market Size Market Share by Type (2019-2024)
6.4 Global Recombinant DNA Technology Price by Type (2019-2024)
7 RECOMBINANT DNA TECHNOLOGY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant DNA Technology Market Sales by Application (2019-2024)
7.3 Global Recombinant DNA Technology Market Size (M USD) by Application (2019-2024)
7.4 Global Recombinant DNA Technology Sales Growth Rate by Application (2019-2024)
8 RECOMBINANT DNA TECHNOLOGY MARKET SEGMENTATION BY REGION
8.1 Global Recombinant DNA Technology Sales by Region
8.1.1 Global Recombinant DNA Technology Sales by Region
8.1.2 Global Recombinant DNA Technology Sales Market Share by Region
8.2 North America
8.2.1 North America Recombinant DNA Technology Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Recombinant DNA Technology Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Recombinant DNA Technology Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Recombinant DNA Technology Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Recombinant DNA Technology Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Monsanto Company
9.1.1 Monsanto Company Recombinant DNA Technology Basic Information
9.1.2 Monsanto Company Recombinant DNA Technology Product Overview
9.1.3 Monsanto Company Recombinant DNA Technology Product Market Performance
9.1.4 Monsanto Company Business Overview
9.1.5 Monsanto Company Recombinant DNA Technology SWOT Analysis
9.1.6 Monsanto Company Recent Developments
9.2 Roche
9.2.1 Roche Recombinant DNA Technology Basic Information
9.2.2 Roche Recombinant DNA Technology Product Overview
9.2.3 Roche Recombinant DNA Technology Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche Recombinant DNA Technology SWOT Analysis
9.2.6 Roche Recent Developments
9.3 Biogen
9.3.1 Biogen Recombinant DNA Technology Basic Information
9.3.2 Biogen Recombinant DNA Technology Product Overview
9.3.3 Biogen Recombinant DNA Technology Product Market Performance
9.3.4 Biogen Recombinant DNA Technology SWOT Analysis
9.3.5 Biogen Business Overview
9.3.6 Biogen Recent Developments
9.4 Amgen
9.4.1 Amgen Recombinant DNA Technology Basic Information
9.4.2 Amgen Recombinant DNA Technology Product Overview
9.4.3 Amgen Recombinant DNA Technology Product Market Performance
9.4.4 Amgen Business Overview
9.4.5 Amgen Recent Developments
9.5 Novartis
9.5.1 Novartis Recombinant DNA Technology Basic Information
9.5.2 Novartis Recombinant DNA Technology Product Overview
9.5.3 Novartis Recombinant DNA Technology Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 Eli Lilly and Company
9.6.1 Eli Lilly and Company Recombinant DNA Technology Basic Information
9.6.2 Eli Lilly and Company Recombinant DNA Technology Product Overview
9.6.3 Eli Lilly and Company Recombinant DNA Technology Product Market Performance
9.6.4 Eli Lilly and Company Business Overview
9.6.5 Eli Lilly and Company Recent Developments
9.7 GenScript
9.7.1 GenScript Recombinant DNA Technology Basic Information
9.7.2 GenScript Recombinant DNA Technology Product Overview
9.7.3 GenScript Recombinant DNA Technology Product Market Performance
9.7.4 GenScript Business Overview
9.7.5 GenScript Recent Developments
9.8 Pfizer Inc.
9.8.1 Pfizer Inc. Recombinant DNA Technology Basic Information
9.8.2 Pfizer Inc. Recombinant DNA Technology Product Overview
9.8.3 Pfizer Inc. Recombinant DNA Technology Product Market Performance
9.8.4 Pfizer Inc. Business Overview
9.8.5 Pfizer Inc. Recent Developments
9.9 Novo Nordisk
9.9.1 Novo Nordisk Recombinant DNA Technology Basic Information
9.9.2 Novo Nordisk Recombinant DNA Technology Product Overview
9.9.3 Novo Nordisk Recombinant DNA Technology Product Market Performance
9.9.4 Novo Nordisk Business Overview
9.9.5 Novo Nordisk Recent Developments
9.10 Sanofi
9.10.1 Sanofi Recombinant DNA Technology Basic Information
9.10.2 Sanofi Recombinant DNA Technology Product Overview
9.10.3 Sanofi Recombinant DNA Technology Product Market Performance
9.10.4 Sanofi Business Overview
9.10.5 Sanofi Recent Developments
9.11 Merck KGaA
9.11.1 Merck KGaA Recombinant DNA Technology Basic Information
9.11.2 Merck KGaA Recombinant DNA Technology Product Overview
9.11.3 Merck KGaA Recombinant DNA Technology Product Market Performance
9.11.4 Merck KGaA Business Overview
9.11.5 Merck KGaA Recent Developments
9.12 Profacgen
9.12.1 Profacgen Recombinant DNA Technology Basic Information
9.12.2 Profacgen Recombinant DNA Technology Product Overview
9.12.3 Profacgen Recombinant DNA Technology Product Market Performance
9.12.4 Profacgen Business Overview
9.12.5 Profacgen Recent Developments
9.13 Biocon
9.13.1 Biocon Recombinant DNA Technology Basic Information
9.13.2 Biocon Recombinant DNA Technology Product Overview
9.13.3 Biocon Recombinant DNA Technology Product Market Performance
9.13.4 Biocon Business Overview
9.13.5 Biocon Recent Developments
9.14 GlaxoSmithKline
9.14.1 GlaxoSmithKline Recombinant DNA Technology Basic Information
9.14.2 GlaxoSmithKline Recombinant DNA Technology Product Overview
9.14.3 GlaxoSmithKline Recombinant DNA Technology Product Market Performance
9.14.4 GlaxoSmithKline Business Overview
9.14.5 GlaxoSmithKline Recent Developments
9.15 Cibus
9.15.1 Cibus Recombinant DNA Technology Basic Information
9.15.2 Cibus Recombinant DNA Technology Product Overview
9.15.3 Cibus Recombinant DNA Technology Product Market Performance
9.15.4 Cibus Business Overview
9.15.5 Cibus Recent Developments
9.16 Horizon Discovery Group
9.16.1 Horizon Discovery Group Recombinant DNA Technology Basic Information
9.16.2 Horizon Discovery Group Recombinant DNA Technology Product Overview
9.16.3 Horizon Discovery Group Recombinant DNA Technology Product Market Performance
9.16.4 Horizon Discovery Group Business Overview
9.16.5 Horizon Discovery Group Recent Developments
9.17 New England Biolabs
9.17.1 New England Biolabs Recombinant DNA Technology Basic Information
9.17.2 New England Biolabs Recombinant DNA Technology Product Overview
9.17.3 New England Biolabs Recombinant DNA Technology Product Market Performance
9.17.4 New England Biolabs Business Overview
9.17.5 New England Biolabs Recent Developments
10 RECOMBINANT DNA TECHNOLOGY MARKET FORECAST BY REGION
10.1 Global Recombinant DNA Technology Market Size Forecast
10.2 Global Recombinant DNA Technology Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Recombinant DNA Technology Market Size Forecast by Country
10.2.3 Asia Pacific Recombinant DNA Technology Market Size Forecast by Region
10.2.4 South America Recombinant DNA Technology Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Recombinant DNA Technology by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Recombinant DNA Technology Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Recombinant DNA Technology by Type (2025-2030)
11.1.2 Global Recombinant DNA Technology Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Recombinant DNA Technology by Type (2025-2030)
11.2 Global Recombinant DNA Technology Market Forecast by Application (2025-2030)
11.2.1 Global Recombinant DNA Technology Sales (K Units) Forecast by Application
11.2.2 Global Recombinant DNA Technology Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Recombinant DNA Technology
1.2 Key Market Segments
1.2.1 Recombinant DNA Technology Segment by Type
1.2.2 Recombinant DNA Technology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RECOMBINANT DNA TECHNOLOGY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Recombinant DNA Technology Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Recombinant DNA Technology Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RECOMBINANT DNA TECHNOLOGY MARKET COMPETITIVE LANDSCAPE
3.1 Global Recombinant DNA Technology Sales by Manufacturers (2019-2024)
3.2 Global Recombinant DNA Technology Revenue Market Share by Manufacturers (2019-2024)
3.3 Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Recombinant DNA Technology Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Recombinant DNA Technology Sales Sites, Area Served, Product Type
3.6 Recombinant DNA Technology Market Competitive Situation and Trends
3.6.1 Recombinant DNA Technology Market Concentration Rate
3.6.2 Global 5 and 10 Largest Recombinant DNA Technology Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RECOMBINANT DNA TECHNOLOGY INDUSTRY CHAIN ANALYSIS
4.1 Recombinant DNA Technology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RECOMBINANT DNA TECHNOLOGY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RECOMBINANT DNA TECHNOLOGY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant DNA Technology Sales Market Share by Type (2019-2024)
6.3 Global Recombinant DNA Technology Market Size Market Share by Type (2019-2024)
6.4 Global Recombinant DNA Technology Price by Type (2019-2024)
7 RECOMBINANT DNA TECHNOLOGY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant DNA Technology Market Sales by Application (2019-2024)
7.3 Global Recombinant DNA Technology Market Size (M USD) by Application (2019-2024)
7.4 Global Recombinant DNA Technology Sales Growth Rate by Application (2019-2024)
8 RECOMBINANT DNA TECHNOLOGY MARKET SEGMENTATION BY REGION
8.1 Global Recombinant DNA Technology Sales by Region
8.1.1 Global Recombinant DNA Technology Sales by Region
8.1.2 Global Recombinant DNA Technology Sales Market Share by Region
8.2 North America
8.2.1 North America Recombinant DNA Technology Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Recombinant DNA Technology Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Recombinant DNA Technology Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Recombinant DNA Technology Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Recombinant DNA Technology Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Monsanto Company
9.1.1 Monsanto Company Recombinant DNA Technology Basic Information
9.1.2 Monsanto Company Recombinant DNA Technology Product Overview
9.1.3 Monsanto Company Recombinant DNA Technology Product Market Performance
9.1.4 Monsanto Company Business Overview
9.1.5 Monsanto Company Recombinant DNA Technology SWOT Analysis
9.1.6 Monsanto Company Recent Developments
9.2 Roche
9.2.1 Roche Recombinant DNA Technology Basic Information
9.2.2 Roche Recombinant DNA Technology Product Overview
9.2.3 Roche Recombinant DNA Technology Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche Recombinant DNA Technology SWOT Analysis
9.2.6 Roche Recent Developments
9.3 Biogen
9.3.1 Biogen Recombinant DNA Technology Basic Information
9.3.2 Biogen Recombinant DNA Technology Product Overview
9.3.3 Biogen Recombinant DNA Technology Product Market Performance
9.3.4 Biogen Recombinant DNA Technology SWOT Analysis
9.3.5 Biogen Business Overview
9.3.6 Biogen Recent Developments
9.4 Amgen
9.4.1 Amgen Recombinant DNA Technology Basic Information
9.4.2 Amgen Recombinant DNA Technology Product Overview
9.4.3 Amgen Recombinant DNA Technology Product Market Performance
9.4.4 Amgen Business Overview
9.4.5 Amgen Recent Developments
9.5 Novartis
9.5.1 Novartis Recombinant DNA Technology Basic Information
9.5.2 Novartis Recombinant DNA Technology Product Overview
9.5.3 Novartis Recombinant DNA Technology Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 Eli Lilly and Company
9.6.1 Eli Lilly and Company Recombinant DNA Technology Basic Information
9.6.2 Eli Lilly and Company Recombinant DNA Technology Product Overview
9.6.3 Eli Lilly and Company Recombinant DNA Technology Product Market Performance
9.6.4 Eli Lilly and Company Business Overview
9.6.5 Eli Lilly and Company Recent Developments
9.7 GenScript
9.7.1 GenScript Recombinant DNA Technology Basic Information
9.7.2 GenScript Recombinant DNA Technology Product Overview
9.7.3 GenScript Recombinant DNA Technology Product Market Performance
9.7.4 GenScript Business Overview
9.7.5 GenScript Recent Developments
9.8 Pfizer Inc.
9.8.1 Pfizer Inc. Recombinant DNA Technology Basic Information
9.8.2 Pfizer Inc. Recombinant DNA Technology Product Overview
9.8.3 Pfizer Inc. Recombinant DNA Technology Product Market Performance
9.8.4 Pfizer Inc. Business Overview
9.8.5 Pfizer Inc. Recent Developments
9.9 Novo Nordisk
9.9.1 Novo Nordisk Recombinant DNA Technology Basic Information
9.9.2 Novo Nordisk Recombinant DNA Technology Product Overview
9.9.3 Novo Nordisk Recombinant DNA Technology Product Market Performance
9.9.4 Novo Nordisk Business Overview
9.9.5 Novo Nordisk Recent Developments
9.10 Sanofi
9.10.1 Sanofi Recombinant DNA Technology Basic Information
9.10.2 Sanofi Recombinant DNA Technology Product Overview
9.10.3 Sanofi Recombinant DNA Technology Product Market Performance
9.10.4 Sanofi Business Overview
9.10.5 Sanofi Recent Developments
9.11 Merck KGaA
9.11.1 Merck KGaA Recombinant DNA Technology Basic Information
9.11.2 Merck KGaA Recombinant DNA Technology Product Overview
9.11.3 Merck KGaA Recombinant DNA Technology Product Market Performance
9.11.4 Merck KGaA Business Overview
9.11.5 Merck KGaA Recent Developments
9.12 Profacgen
9.12.1 Profacgen Recombinant DNA Technology Basic Information
9.12.2 Profacgen Recombinant DNA Technology Product Overview
9.12.3 Profacgen Recombinant DNA Technology Product Market Performance
9.12.4 Profacgen Business Overview
9.12.5 Profacgen Recent Developments
9.13 Biocon
9.13.1 Biocon Recombinant DNA Technology Basic Information
9.13.2 Biocon Recombinant DNA Technology Product Overview
9.13.3 Biocon Recombinant DNA Technology Product Market Performance
9.13.4 Biocon Business Overview
9.13.5 Biocon Recent Developments
9.14 GlaxoSmithKline
9.14.1 GlaxoSmithKline Recombinant DNA Technology Basic Information
9.14.2 GlaxoSmithKline Recombinant DNA Technology Product Overview
9.14.3 GlaxoSmithKline Recombinant DNA Technology Product Market Performance
9.14.4 GlaxoSmithKline Business Overview
9.14.5 GlaxoSmithKline Recent Developments
9.15 Cibus
9.15.1 Cibus Recombinant DNA Technology Basic Information
9.15.2 Cibus Recombinant DNA Technology Product Overview
9.15.3 Cibus Recombinant DNA Technology Product Market Performance
9.15.4 Cibus Business Overview
9.15.5 Cibus Recent Developments
9.16 Horizon Discovery Group
9.16.1 Horizon Discovery Group Recombinant DNA Technology Basic Information
9.16.2 Horizon Discovery Group Recombinant DNA Technology Product Overview
9.16.3 Horizon Discovery Group Recombinant DNA Technology Product Market Performance
9.16.4 Horizon Discovery Group Business Overview
9.16.5 Horizon Discovery Group Recent Developments
9.17 New England Biolabs
9.17.1 New England Biolabs Recombinant DNA Technology Basic Information
9.17.2 New England Biolabs Recombinant DNA Technology Product Overview
9.17.3 New England Biolabs Recombinant DNA Technology Product Market Performance
9.17.4 New England Biolabs Business Overview
9.17.5 New England Biolabs Recent Developments
10 RECOMBINANT DNA TECHNOLOGY MARKET FORECAST BY REGION
10.1 Global Recombinant DNA Technology Market Size Forecast
10.2 Global Recombinant DNA Technology Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Recombinant DNA Technology Market Size Forecast by Country
10.2.3 Asia Pacific Recombinant DNA Technology Market Size Forecast by Region
10.2.4 South America Recombinant DNA Technology Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Recombinant DNA Technology by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Recombinant DNA Technology Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Recombinant DNA Technology by Type (2025-2030)
11.1.2 Global Recombinant DNA Technology Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Recombinant DNA Technology by Type (2025-2030)
11.2 Global Recombinant DNA Technology Market Forecast by Application (2025-2030)
11.2.1 Global Recombinant DNA Technology Sales (K Units) Forecast by Application
11.2.2 Global Recombinant DNA Technology Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Recombinant DNA Technology Market Size Comparison by Region (M USD)
Table 5. Global Recombinant DNA Technology Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Recombinant DNA Technology Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Recombinant DNA Technology Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Recombinant DNA Technology Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2022)
Table 10. Global Market Recombinant DNA Technology Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Recombinant DNA Technology Sales Sites and Area Served
Table 12. Manufacturers Recombinant DNA Technology Product Type
Table 13. Global Recombinant DNA Technology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Recombinant DNA Technology
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Recombinant DNA Technology Market Challenges
Table 22. Global Recombinant DNA Technology Sales by Type (K Units)
Table 23. Global Recombinant DNA Technology Market Size by Type (M USD)
Table 24. Global Recombinant DNA Technology Sales (K Units) by Type (2019-2024)
Table 25. Global Recombinant DNA Technology Sales Market Share by Type (2019-2024)
Table 26. Global Recombinant DNA Technology Market Size (M USD) by Type (2019-2024)
Table 27. Global Recombinant DNA Technology Market Size Share by Type (2019-2024)
Table 28. Global Recombinant DNA Technology Price (USD/Unit) by Type (2019-2024)
Table 29. Global Recombinant DNA Technology Sales (K Units) by Application
Table 30. Global Recombinant DNA Technology Market Size by Application
Table 31. Global Recombinant DNA Technology Sales by Application (2019-2024) & (K Units)
Table 32. Global Recombinant DNA Technology Sales Market Share by Application (2019-2024)
Table 33. Global Recombinant DNA Technology Sales by Application (2019-2024) & (M USD)
Table 34. Global Recombinant DNA Technology Market Share by Application (2019-2024)
Table 35. Global Recombinant DNA Technology Sales Growth Rate by Application (2019-2024)
Table 36. Global Recombinant DNA Technology Sales by Region (2019-2024) & (K Units)
Table 37. Global Recombinant DNA Technology Sales Market Share by Region (2019-2024)
Table 38. North America Recombinant DNA Technology Sales by Country (2019-2024) & (K Units)
Table 39. Europe Recombinant DNA Technology Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Recombinant DNA Technology Sales by Region (2019-2024) & (K Units)
Table 41. South America Recombinant DNA Technology Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Recombinant DNA Technology Sales by Region (2019-2024) & (K Units)
Table 43. Monsanto Company Recombinant DNA Technology Basic Information
Table 44. Monsanto Company Recombinant DNA Technology Product Overview
Table 45. Monsanto Company Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Monsanto Company Business Overview
Table 47. Monsanto Company Recombinant DNA Technology SWOT Analysis
Table 48. Monsanto Company Recent Developments
Table 49. Roche Recombinant DNA Technology Basic Information
Table 50. Roche Recombinant DNA Technology Product Overview
Table 51. Roche Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Roche Business Overview
Table 53. Roche Recombinant DNA Technology SWOT Analysis
Table 54. Roche Recent Developments
Table 55. Biogen Recombinant DNA Technology Basic Information
Table 56. Biogen Recombinant DNA Technology Product Overview
Table 57. Biogen Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Biogen Recombinant DNA Technology SWOT Analysis
Table 59. Biogen Business Overview
Table 60. Biogen Recent Developments
Table 61. Amgen Recombinant DNA Technology Basic Information
Table 62. Amgen Recombinant DNA Technology Product Overview
Table 63. Amgen Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Amgen Business Overview
Table 65. Amgen Recent Developments
Table 66. Novartis Recombinant DNA Technology Basic Information
Table 67. Novartis Recombinant DNA Technology Product Overview
Table 68. Novartis Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Novartis Business Overview
Table 70. Novartis Recent Developments
Table 71. Eli Lilly and Company Recombinant DNA Technology Basic Information
Table 72. Eli Lilly and Company Recombinant DNA Technology Product Overview
Table 73. Eli Lilly and Company Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Eli Lilly and Company Business Overview
Table 75. Eli Lilly and Company Recent Developments
Table 76. GenScript Recombinant DNA Technology Basic Information
Table 77. GenScript Recombinant DNA Technology Product Overview
Table 78. GenScript Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. GenScript Business Overview
Table 80. GenScript Recent Developments
Table 81. Pfizer Inc. Recombinant DNA Technology Basic Information
Table 82. Pfizer Inc. Recombinant DNA Technology Product Overview
Table 83. Pfizer Inc. Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Pfizer Inc. Business Overview
Table 85. Pfizer Inc. Recent Developments
Table 86. Novo Nordisk Recombinant DNA Technology Basic Information
Table 87. Novo Nordisk Recombinant DNA Technology Product Overview
Table 88. Novo Nordisk Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Novo Nordisk Business Overview
Table 90. Novo Nordisk Recent Developments
Table 91. Sanofi Recombinant DNA Technology Basic Information
Table 92. Sanofi Recombinant DNA Technology Product Overview
Table 93. Sanofi Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Sanofi Business Overview
Table 95. Sanofi Recent Developments
Table 96. Merck KGaA Recombinant DNA Technology Basic Information
Table 97. Merck KGaA Recombinant DNA Technology Product Overview
Table 98. Merck KGaA Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Merck KGaA Business Overview
Table 100. Merck KGaA Recent Developments
Table 101. Profacgen Recombinant DNA Technology Basic Information
Table 102. Profacgen Recombinant DNA Technology Product Overview
Table 103. Profacgen Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Profacgen Business Overview
Table 105. Profacgen Recent Developments
Table 106. Biocon Recombinant DNA Technology Basic Information
Table 107. Biocon Recombinant DNA Technology Product Overview
Table 108. Biocon Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Biocon Business Overview
Table 110. Biocon Recent Developments
Table 111. GlaxoSmithKline Recombinant DNA Technology Basic Information
Table 112. GlaxoSmithKline Recombinant DNA Technology Product Overview
Table 113. GlaxoSmithKline Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. GlaxoSmithKline Business Overview
Table 115. GlaxoSmithKline Recent Developments
Table 116. Cibus Recombinant DNA Technology Basic Information
Table 117. Cibus Recombinant DNA Technology Product Overview
Table 118. Cibus Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Cibus Business Overview
Table 120. Cibus Recent Developments
Table 121. Horizon Discovery Group Recombinant DNA Technology Basic Information
Table 122. Horizon Discovery Group Recombinant DNA Technology Product Overview
Table 123. Horizon Discovery Group Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Horizon Discovery Group Business Overview
Table 125. Horizon Discovery Group Recent Developments
Table 126. New England Biolabs Recombinant DNA Technology Basic Information
Table 127. New England Biolabs Recombinant DNA Technology Product Overview
Table 128. New England Biolabs Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. New England Biolabs Business Overview
Table 130. New England Biolabs Recent Developments
Table 131. Global Recombinant DNA Technology Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global Recombinant DNA Technology Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Recombinant DNA Technology Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America Recombinant DNA Technology Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Recombinant DNA Technology Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe Recombinant DNA Technology Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Recombinant DNA Technology Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific Recombinant DNA Technology Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Recombinant DNA Technology Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America Recombinant DNA Technology Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Recombinant DNA Technology Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Recombinant DNA Technology Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Recombinant DNA Technology Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global Recombinant DNA Technology Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Recombinant DNA Technology Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global Recombinant DNA Technology Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global Recombinant DNA Technology Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Recombinant DNA Technology Market Size Comparison by Region (M USD)
Table 5. Global Recombinant DNA Technology Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Recombinant DNA Technology Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Recombinant DNA Technology Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Recombinant DNA Technology Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2022)
Table 10. Global Market Recombinant DNA Technology Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Recombinant DNA Technology Sales Sites and Area Served
Table 12. Manufacturers Recombinant DNA Technology Product Type
Table 13. Global Recombinant DNA Technology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Recombinant DNA Technology
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Recombinant DNA Technology Market Challenges
Table 22. Global Recombinant DNA Technology Sales by Type (K Units)
Table 23. Global Recombinant DNA Technology Market Size by Type (M USD)
Table 24. Global Recombinant DNA Technology Sales (K Units) by Type (2019-2024)
Table 25. Global Recombinant DNA Technology Sales Market Share by Type (2019-2024)
Table 26. Global Recombinant DNA Technology Market Size (M USD) by Type (2019-2024)
Table 27. Global Recombinant DNA Technology Market Size Share by Type (2019-2024)
Table 28. Global Recombinant DNA Technology Price (USD/Unit) by Type (2019-2024)
Table 29. Global Recombinant DNA Technology Sales (K Units) by Application
Table 30. Global Recombinant DNA Technology Market Size by Application
Table 31. Global Recombinant DNA Technology Sales by Application (2019-2024) & (K Units)
Table 32. Global Recombinant DNA Technology Sales Market Share by Application (2019-2024)
Table 33. Global Recombinant DNA Technology Sales by Application (2019-2024) & (M USD)
Table 34. Global Recombinant DNA Technology Market Share by Application (2019-2024)
Table 35. Global Recombinant DNA Technology Sales Growth Rate by Application (2019-2024)
Table 36. Global Recombinant DNA Technology Sales by Region (2019-2024) & (K Units)
Table 37. Global Recombinant DNA Technology Sales Market Share by Region (2019-2024)
Table 38. North America Recombinant DNA Technology Sales by Country (2019-2024) & (K Units)
Table 39. Europe Recombinant DNA Technology Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Recombinant DNA Technology Sales by Region (2019-2024) & (K Units)
Table 41. South America Recombinant DNA Technology Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Recombinant DNA Technology Sales by Region (2019-2024) & (K Units)
Table 43. Monsanto Company Recombinant DNA Technology Basic Information
Table 44. Monsanto Company Recombinant DNA Technology Product Overview
Table 45. Monsanto Company Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Monsanto Company Business Overview
Table 47. Monsanto Company Recombinant DNA Technology SWOT Analysis
Table 48. Monsanto Company Recent Developments
Table 49. Roche Recombinant DNA Technology Basic Information
Table 50. Roche Recombinant DNA Technology Product Overview
Table 51. Roche Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Roche Business Overview
Table 53. Roche Recombinant DNA Technology SWOT Analysis
Table 54. Roche Recent Developments
Table 55. Biogen Recombinant DNA Technology Basic Information
Table 56. Biogen Recombinant DNA Technology Product Overview
Table 57. Biogen Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Biogen Recombinant DNA Technology SWOT Analysis
Table 59. Biogen Business Overview
Table 60. Biogen Recent Developments
Table 61. Amgen Recombinant DNA Technology Basic Information
Table 62. Amgen Recombinant DNA Technology Product Overview
Table 63. Amgen Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Amgen Business Overview
Table 65. Amgen Recent Developments
Table 66. Novartis Recombinant DNA Technology Basic Information
Table 67. Novartis Recombinant DNA Technology Product Overview
Table 68. Novartis Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Novartis Business Overview
Table 70. Novartis Recent Developments
Table 71. Eli Lilly and Company Recombinant DNA Technology Basic Information
Table 72. Eli Lilly and Company Recombinant DNA Technology Product Overview
Table 73. Eli Lilly and Company Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Eli Lilly and Company Business Overview
Table 75. Eli Lilly and Company Recent Developments
Table 76. GenScript Recombinant DNA Technology Basic Information
Table 77. GenScript Recombinant DNA Technology Product Overview
Table 78. GenScript Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. GenScript Business Overview
Table 80. GenScript Recent Developments
Table 81. Pfizer Inc. Recombinant DNA Technology Basic Information
Table 82. Pfizer Inc. Recombinant DNA Technology Product Overview
Table 83. Pfizer Inc. Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Pfizer Inc. Business Overview
Table 85. Pfizer Inc. Recent Developments
Table 86. Novo Nordisk Recombinant DNA Technology Basic Information
Table 87. Novo Nordisk Recombinant DNA Technology Product Overview
Table 88. Novo Nordisk Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Novo Nordisk Business Overview
Table 90. Novo Nordisk Recent Developments
Table 91. Sanofi Recombinant DNA Technology Basic Information
Table 92. Sanofi Recombinant DNA Technology Product Overview
Table 93. Sanofi Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Sanofi Business Overview
Table 95. Sanofi Recent Developments
Table 96. Merck KGaA Recombinant DNA Technology Basic Information
Table 97. Merck KGaA Recombinant DNA Technology Product Overview
Table 98. Merck KGaA Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Merck KGaA Business Overview
Table 100. Merck KGaA Recent Developments
Table 101. Profacgen Recombinant DNA Technology Basic Information
Table 102. Profacgen Recombinant DNA Technology Product Overview
Table 103. Profacgen Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Profacgen Business Overview
Table 105. Profacgen Recent Developments
Table 106. Biocon Recombinant DNA Technology Basic Information
Table 107. Biocon Recombinant DNA Technology Product Overview
Table 108. Biocon Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Biocon Business Overview
Table 110. Biocon Recent Developments
Table 111. GlaxoSmithKline Recombinant DNA Technology Basic Information
Table 112. GlaxoSmithKline Recombinant DNA Technology Product Overview
Table 113. GlaxoSmithKline Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. GlaxoSmithKline Business Overview
Table 115. GlaxoSmithKline Recent Developments
Table 116. Cibus Recombinant DNA Technology Basic Information
Table 117. Cibus Recombinant DNA Technology Product Overview
Table 118. Cibus Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Cibus Business Overview
Table 120. Cibus Recent Developments
Table 121. Horizon Discovery Group Recombinant DNA Technology Basic Information
Table 122. Horizon Discovery Group Recombinant DNA Technology Product Overview
Table 123. Horizon Discovery Group Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Horizon Discovery Group Business Overview
Table 125. Horizon Discovery Group Recent Developments
Table 126. New England Biolabs Recombinant DNA Technology Basic Information
Table 127. New England Biolabs Recombinant DNA Technology Product Overview
Table 128. New England Biolabs Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. New England Biolabs Business Overview
Table 130. New England Biolabs Recent Developments
Table 131. Global Recombinant DNA Technology Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global Recombinant DNA Technology Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Recombinant DNA Technology Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America Recombinant DNA Technology Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Recombinant DNA Technology Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe Recombinant DNA Technology Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Recombinant DNA Technology Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific Recombinant DNA Technology Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Recombinant DNA Technology Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America Recombinant DNA Technology Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Recombinant DNA Technology Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Recombinant DNA Technology Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Recombinant DNA Technology Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global Recombinant DNA Technology Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Recombinant DNA Technology Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global Recombinant DNA Technology Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global Recombinant DNA Technology Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Recombinant DNA Technology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant DNA Technology Market Size (M USD), 2019-2030
Figure 5. Global Recombinant DNA Technology Market Size (M USD) (2019-2030)
Figure 6. Global Recombinant DNA Technology Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant DNA Technology Market Size by Country (M USD)
Figure 11. Recombinant DNA Technology Sales Share by Manufacturers in 2023
Figure 12. Global Recombinant DNA Technology Revenue Share by Manufacturers in 2023
Figure 13. Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Recombinant DNA Technology Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Recombinant DNA Technology Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Recombinant DNA Technology Market Share by Type
Figure 18. Sales Market Share of Recombinant DNA Technology by Type (2019-2024)
Figure 19. Sales Market Share of Recombinant DNA Technology by Type in 2023
Figure 20. Market Size Share of Recombinant DNA Technology by Type (2019-2024)
Figure 21. Market Size Market Share of Recombinant DNA Technology by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Recombinant DNA Technology Market Share by Application
Figure 24. Global Recombinant DNA Technology Sales Market Share by Application (2019-2024)
Figure 25. Global Recombinant DNA Technology Sales Market Share by Application in 2023
Figure 26. Global Recombinant DNA Technology Market Share by Application (2019-2024)
Figure 27. Global Recombinant DNA Technology Market Share by Application in 2023
Figure 28. Global Recombinant DNA Technology Sales Growth Rate by Application (2019-2024)
Figure 29. Global Recombinant DNA Technology Sales Market Share by Region (2019-2024)
Figure 30. North America Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Recombinant DNA Technology Sales Market Share by Country in 2023
Figure 32. U.S. Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Recombinant DNA Technology Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Recombinant DNA Technology Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Recombinant DNA Technology Sales Market Share by Country in 2023
Figure 37. Germany Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Recombinant DNA Technology Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Recombinant DNA Technology Sales Market Share by Region in 2023
Figure 44. China Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Recombinant DNA Technology Sales and Growth Rate (K Units)
Figure 50. South America Recombinant DNA Technology Sales Market Share by Country in 2023
Figure 51. Brazil Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Recombinant DNA Technology Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Recombinant DNA Technology Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Recombinant DNA Technology Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Recombinant DNA Technology Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Recombinant DNA Technology Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Recombinant DNA Technology Market Share Forecast by Type (2025-2030)
Figure 65. Global Recombinant DNA Technology Sales Forecast by Application (2025-2030)
Figure 66. Global Recombinant DNA Technology Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Recombinant DNA Technology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant DNA Technology Market Size (M USD), 2019-2030
Figure 5. Global Recombinant DNA Technology Market Size (M USD) (2019-2030)
Figure 6. Global Recombinant DNA Technology Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant DNA Technology Market Size by Country (M USD)
Figure 11. Recombinant DNA Technology Sales Share by Manufacturers in 2023
Figure 12. Global Recombinant DNA Technology Revenue Share by Manufacturers in 2023
Figure 13. Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Recombinant DNA Technology Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Recombinant DNA Technology Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Recombinant DNA Technology Market Share by Type
Figure 18. Sales Market Share of Recombinant DNA Technology by Type (2019-2024)
Figure 19. Sales Market Share of Recombinant DNA Technology by Type in 2023
Figure 20. Market Size Share of Recombinant DNA Technology by Type (2019-2024)
Figure 21. Market Size Market Share of Recombinant DNA Technology by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Recombinant DNA Technology Market Share by Application
Figure 24. Global Recombinant DNA Technology Sales Market Share by Application (2019-2024)
Figure 25. Global Recombinant DNA Technology Sales Market Share by Application in 2023
Figure 26. Global Recombinant DNA Technology Market Share by Application (2019-2024)
Figure 27. Global Recombinant DNA Technology Market Share by Application in 2023
Figure 28. Global Recombinant DNA Technology Sales Growth Rate by Application (2019-2024)
Figure 29. Global Recombinant DNA Technology Sales Market Share by Region (2019-2024)
Figure 30. North America Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Recombinant DNA Technology Sales Market Share by Country in 2023
Figure 32. U.S. Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Recombinant DNA Technology Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Recombinant DNA Technology Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Recombinant DNA Technology Sales Market Share by Country in 2023
Figure 37. Germany Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Recombinant DNA Technology Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Recombinant DNA Technology Sales Market Share by Region in 2023
Figure 44. China Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Recombinant DNA Technology Sales and Growth Rate (K Units)
Figure 50. South America Recombinant DNA Technology Sales Market Share by Country in 2023
Figure 51. Brazil Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Recombinant DNA Technology Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Recombinant DNA Technology Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Recombinant DNA Technology Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Recombinant DNA Technology Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Recombinant DNA Technology Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Recombinant DNA Technology Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Recombinant DNA Technology Market Share Forecast by Type (2025-2030)
Figure 65. Global Recombinant DNA Technology Sales Forecast by Application (2025-2030)
Figure 66. Global Recombinant DNA Technology Market Share Forecast by Application (2025-2030)
